20-F/A

FORM 20-F/A

Company: XTL BIOPHARMACEUTICALS LTD
Filed: March 30, 2012
Period of Report: December 31, 2011
Accession Number: 0001144204-12-018782

View Document ↗ View on SEC.gov ↗